Kevzara 200 MG/1.14 ML syringe 1.14ML
Ended Awarded Last action
- Contract number
- SPE2DR26F3G3L
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,506
Award facts
- Contract value 100% obligated
- $13,506.21 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $13.5K delivery order to AmerisourceBergen Drug Corp for the supply of Kevzara 200 mg/1.14 ml syringes, with a completion deadline of January 27, 2026. This is a competitively awarded, firm fixed-price contract with no set-aside designation. The award was issued on January 26, 2026, with performance to be completed at the contractor's facility in Conshohocken, Pennsylvania. Kevzara is a prescription biologic medication used to treat rheumatoid arthritis and is a critical pharmaceutical commodity within the federal healthcare supply chain.
This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical, designated as SPE2DX, valued at $999.99M through December 2026. This prime indefinite delivery vehicle provides comprehensive global pharmaceutical support to military healthcare programs, enabling the delivery of brand-name and generic medications, specialty drugs, vaccines, and medical supplies across multiple therapeutic domains. AmerisourceBergen's parent company is Cencora, Inc., which holds the underlying $999.99M IDC with the DLA through December 2031. The company demonstrates substantial capability in fulfilling federal pharmaceutical procurement requirements through this strategic contract relationship supporting Defense Health Agency operations and broader military healthcare initiatives.
Quick answers
Who was awarded contract SPE2DR26F3G3L?
SPE2DR26F3G3L was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 26, 2026.
How much is contract SPE2DR26F3G3L worth?
The government has obligated $13,506 on SPE2DR26F3G3L.
Is contract SPE2DR26F3G3L an order under another contract?
Yes. SPE2DR26F3G3L is a delivery order under SPE2DR25D3001, an indefinite delivery contract.
Was contract SPE2DR26F3G3L competed?
The extent of competition for SPE2DR26F3G3L was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award